254 related articles for article (PubMed ID: 15761112)
1. Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration.
Rothman RB; Blough BE; Woolverton WL; Anderson KG; Negus SS; Mello NK; Roth BL; Baumann MH
J Pharmacol Exp Ther; 2005 Jun; 313(3):1361-9. PubMed ID: 15761112
[TBL] [Abstract][Full Text] [Related]
2. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
[TBL] [Abstract][Full Text] [Related]
3. Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction.
Rothman RB; Elmer GI; Shippenberg TS; Rea W; Baumann MH
Ann N Y Acad Sci; 1998 May; 844():59-74. PubMed ID: 9668665
[TBL] [Abstract][Full Text] [Related]
4. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
[TBL] [Abstract][Full Text] [Related]
5. Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys.
Negus SS; Mello NK; Blough BE; Baumann MH; Rothman RB
J Pharmacol Exp Ther; 2007 Feb; 320(2):627-36. PubMed ID: 17071819
[TBL] [Abstract][Full Text] [Related]
6. Acute and subacute effects of risperidone and cocaine on accumbens dopamine and serotonin release using in vivo microvoltammetry on line with open-field behavior.
Broderick PA; Rahni DN; Zhou Y
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):1037-54. PubMed ID: 14499322
[TBL] [Abstract][Full Text] [Related]
7. Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs.
Rothman RB; Baumann MH
Ann N Y Acad Sci; 2006 Aug; 1074():245-60. PubMed ID: 17105921
[TBL] [Abstract][Full Text] [Related]
8. Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.
Villemagne VL; Rothman RB; Yokoi F; Rice KC; Matecka D; Dannals RF; Wong DF
Synapse; 1999 Apr; 32(1):44-50. PubMed ID: 10188637
[TBL] [Abstract][Full Text] [Related]
9. Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs.
Wee S; Anderson KG; Baumann MH; Rothman RB; Blough BE; Woolverton WL
J Pharmacol Exp Ther; 2005 May; 313(2):848-54. PubMed ID: 15677348
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of 3-(3,4-dichlorophenyl)-1-indanamine derivatives as nonselective ligands for biogenic amine transporters.
Yu H; Kim IJ; Folk JE; Tian X; Rothman RB; Baumann MH; Dersch CM; Flippen-Anderson JL; Parrish D; Jacobson AE; Rice KC
J Med Chem; 2004 May; 47(10):2624-34. PubMed ID: 15115403
[TBL] [Abstract][Full Text] [Related]
11. Reinforcing effect of pseudoephedrine isomers and the mechanism of action.
Wee S; Ordway GA; Woolverton WL
Eur J Pharmacol; 2004 Jun; 493(1-3):117-25. PubMed ID: 15189772
[TBL] [Abstract][Full Text] [Related]
12. Effects of methcathinone and 3-Cl-methcathinone (PAL-434) in cocaine discrimination or self-administration in rhesus monkeys.
Kohut SJ; Fivel PA; Blough BE; Rothman RB; Mello NK
Int J Neuropsychopharmacol; 2013 Oct; 16(9):1985-98. PubMed ID: 23768644
[TBL] [Abstract][Full Text] [Related]
13. Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice.
Rothman RB; Carroll FI; Morales M; Rowley DL; Rice KC; Dersch CM; Donovan DM
Synapse; 2002 May; 44(2):94-105. PubMed ID: 11891881
[TBL] [Abstract][Full Text] [Related]
14. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.
Rothman RB; Baumann MH; Dersch CM; Romero DV; Rice KC; Carroll FI; Partilla JS
Synapse; 2001 Jan; 39(1):32-41. PubMed ID: 11071707
[TBL] [Abstract][Full Text] [Related]
15. Autoregulation and monoamine interactions in the ventral tegmental area in the absence and presence of cocaine: a microdialysis study in freely moving rats.
Chen NH; Reith ME
J Pharmacol Exp Ther; 1994 Dec; 271(3):1597-610. PubMed ID: 7996474
[TBL] [Abstract][Full Text] [Related]
16. Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions.
Rothman RB; Blough BE; Baumann MH
AAPS J; 2007 Jan; 9(1):E1-10. PubMed ID: 17408232
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants.
Brown JM; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine.
Tella SR; Ladenheim B; Cadet JL
J Pharmacol Exp Ther; 1997 Apr; 281(1):508-13. PubMed ID: 9103538
[TBL] [Abstract][Full Text] [Related]
19. In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats.
Baumann MH; Rothman RB; Pablo JP; Mash DC
J Pharmacol Exp Ther; 2001 May; 297(2):531-9. PubMed ID: 11303040
[TBL] [Abstract][Full Text] [Related]
20. Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study.
Gerasimov MR; Franceschi M; Volkow ND; Gifford A; Gatley SJ; Marsteller D; Molina PE; Dewey SL
J Pharmacol Exp Ther; 2000 Oct; 295(1):51-7. PubMed ID: 10991960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
